JP2015520232A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520232A5
JP2015520232A5 JP2015518471A JP2015518471A JP2015520232A5 JP 2015520232 A5 JP2015520232 A5 JP 2015520232A5 JP 2015518471 A JP2015518471 A JP 2015518471A JP 2015518471 A JP2015518471 A JP 2015518471A JP 2015520232 A5 JP2015520232 A5 JP 2015520232A5
Authority
JP
Japan
Prior art keywords
amino
triazine
carboxamide
aminocyclohexyl
oxobutan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015518471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015520232A (ja
JP6281984B2 (ja
Filing date
Publication date
Priority claimed from US13/841,472 external-priority patent/US9040530B2/en
Application filed filed Critical
Publication of JP2015520232A publication Critical patent/JP2015520232A/ja
Publication of JP2015520232A5 publication Critical patent/JP2015520232A5/ja
Application granted granted Critical
Publication of JP6281984B2 publication Critical patent/JP6281984B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015518471A 2012-06-22 2013-06-14 1,2,4−トリアジン−6−カルボキサミドキナーゼ阻害剤 Active JP6281984B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261663499P 2012-06-22 2012-06-22
US61/663,499 2012-06-22
US13/841,472 US9040530B2 (en) 2012-06-22 2013-03-15 1,2,4-triazine-6-carboxamide kinase inhibitors
US13/841,472 2013-03-15
PCT/US2013/046006 WO2013192049A2 (en) 2012-06-22 2013-06-14 1,2,4-triazine-6-carboxamide kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2015520232A JP2015520232A (ja) 2015-07-16
JP2015520232A5 true JP2015520232A5 (cg-RX-API-DMAC7.html) 2016-06-30
JP6281984B2 JP6281984B2 (ja) 2018-02-21

Family

ID=49769666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015518471A Active JP6281984B2 (ja) 2012-06-22 2013-06-14 1,2,4−トリアジン−6−カルボキサミドキナーゼ阻害剤

Country Status (11)

Country Link
US (1) US9040530B2 (cg-RX-API-DMAC7.html)
EP (1) EP2863748B1 (cg-RX-API-DMAC7.html)
JP (1) JP6281984B2 (cg-RX-API-DMAC7.html)
CN (1) CN104470363A (cg-RX-API-DMAC7.html)
AU (1) AU2013277476B2 (cg-RX-API-DMAC7.html)
CA (1) CA2876945C (cg-RX-API-DMAC7.html)
IL (1) IL236057B (cg-RX-API-DMAC7.html)
IN (1) IN2014KN02906A (cg-RX-API-DMAC7.html)
SG (2) SG10201805392YA (cg-RX-API-DMAC7.html)
WO (1) WO2013192049A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201409256B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013047813A1 (ja) * 2011-09-30 2013-04-04 大鵬薬品工業株式会社 1,2,4-トリアジン-6-カルボキサミド誘導体
HK1211024A1 (en) 2012-10-19 2016-05-13 霍夫曼-拉罗奇有限公司 Inhibitors of syk
PE20150944A1 (es) * 2012-11-08 2015-06-20 Bristol Myers Squibb Co COMPUESTOS HETEROCICLICOS SUSTITUIDOS CON AMIDA UTILES COMO MODULADORES DE LAS RESPUESTAS DE INTERLEUCINA 12(IL-12), INTERLEUCINA 23 (IL-23) Y/O INTERFERON ALFA (IFN(alfa))
BR112015016580A2 (pt) * 2013-01-11 2017-07-11 Fujifilm Corp composto heterocíclico contendo nitrogênio ou sal deste
CN104870437A (zh) * 2013-01-17 2015-08-26 四川恒康发展有限责任公司 三嗪化合物、其药用盐、异构体或水合物及其药物组合物
JP2016113366A (ja) * 2013-03-29 2016-06-23 大鵬薬品工業株式会社 アセトアミド基を有する1,2,4−トリアジン−6−カルボキサミド誘導体
AU2014360446A1 (en) 2013-12-05 2016-06-09 Pharmacyclics, Llc Inhibitors of Bruton's tyrosine kinase
EP3310776A4 (en) * 2015-06-02 2019-01-16 Pharmacyclics LLC BRUTON TYROSINE KINASE HEMMER
CN109384774B (zh) * 2017-08-11 2023-02-17 中国科学院上海药物研究所 一类多取代的吡嗪/三嗪酰胺类化合物及其制备方法和应用
US12428395B2 (en) 2019-08-01 2025-09-30 Sperogenix Therapeutics Limited Heterocyclic compounds as kinase inhibitor and uses thereof
US20230159520A1 (en) * 2020-02-26 2023-05-25 Beigene, Ltd. Tyk-2 inhibitor
WO2022032484A1 (zh) * 2020-08-11 2022-02-17 北京诺诚健华医药科技有限公司 哒嗪-3-甲酰胺类化合物、其制备方法及其在医药学上的应用
CN118401516A (zh) * 2021-12-16 2024-07-26 凌科药业(杭州)有限公司 Tyk2抑制剂及其组合物和方法
WO2023108536A1 (en) * 2021-12-16 2023-06-22 Lynk Pharmaceuticals Co. Ltd. Tyk2 inhibitors and compositions and methods thereof
WO2024254832A1 (en) * 2023-06-15 2024-12-19 Lynk Pharmaceuticals Co. Ltd. Tyk2 inhibitors and compositions and methods thereof
CN118175828B (zh) * 2024-05-16 2024-08-16 浙江大华技术股份有限公司 吸波材料、制备方法和器件

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797706B1 (en) * 1999-06-09 2004-09-28 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclecarboxamide derivative
JP4622047B2 (ja) * 1999-06-09 2011-02-02 アステラス製薬株式会社 新規なヘテロ環カルボキサミド誘導体
AU5108000A (en) * 1999-06-10 2001-01-02 Yamanouchi Pharmaceutical Co., Ltd. Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
US7723336B2 (en) 2005-09-22 2010-05-25 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
SG2014015085A (en) * 2008-04-16 2014-06-27 Portola Pharm Inc 2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors
WO2013047813A1 (ja) * 2011-09-30 2013-04-04 大鵬薬品工業株式会社 1,2,4-トリアジン-6-カルボキサミド誘導体
US20130310387A1 (en) * 2012-05-16 2013-11-21 Novartis Ag Monocyclic Heteroaryl Cycloalkyldiamine Derivatives

Similar Documents

Publication Publication Date Title
JP2015520232A5 (cg-RX-API-DMAC7.html)
AU2023270195B2 (en) 2,3-dihydroquinazolin compounds as NAV1.8 inhibitors
JP6281984B2 (ja) 1,2,4−トリアジン−6−カルボキサミドキナーゼ阻害剤
EP1326856B1 (en) Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
AU2005245386B2 (en) Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
US8895585B2 (en) Nicotinamide derivative or salt thereof
AU2002341921B8 (en) Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
JP5868168B2 (ja) 新規なニコチンアミド誘導体またはその塩
JP5847087B2 (ja) オレキシン受容体調節因子としての縮合複素環式化合物
AU2018236691A1 (en) N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
TW202016094A (zh) 週期素依賴性激酶抑制劑
JP2011518158A5 (cg-RX-API-DMAC7.html)
CA2631746A1 (en) Urea compounds useful in the treatment of cancer
TW201925187A (zh) 經碸吡啶烷基醯胺取代之雜芳基化合物
KR20010083055A (ko) 글리코겐 신타제 키나제 3의 억제제
JP2016501186A (ja) キナーゼモジュレーターとして有用なヘテロアリール置換ピリジル化合物
AU2017342928B2 (en) Quinoxaline compounds as type III receptor tyrosine kinase inhibitors
CN109071488A (zh) 取代的1,2,3-三唑作为nr2b-选择性nmda调节剂
AU2005267884A1 (en) Potassium channel inhibitors
WO2004052880A1 (en) Pyridine derivatives as jnk inhibitors and their use
JP7114591B2 (ja) Gsk-3阻害剤
EP1960394A2 (en) Pyrazolyl urea derivatives useful in the treatment of cancer
AU2013302320A1 (en) VEGFR3 inhibitors
KR20210110288A (ko) 치환된 아릴 화합물, 및 이의 제조 방법 및 이의 용도
WO2021117846A1 (ja) Pdgf受容体キナーゼ阻害剤としての化合物および組成物